Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.

Autor: Focan, C, Beauduin, M, Salamon, E, Greve, J de, Wasch, G de, Lobelle, J P, Majois, F, Tagnon, A, Tytgat, J, Belle, S van, Vandervellen, R, Vindevoghel, A
Zdroj: British Journal of Cancer. 7/1/2001, Vol. 85 Issue 1, p1. 8p.
Databáze: Academic Search Ultimate